Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
07/03/2025 | CALL | $48.50 | 13,362 | +6,329 | +89.99% |
01/16/2026 | CALL | $57.50 | 4,299 | +741 | +20.83% |
07/18/2025 | PUT | $46.00 | 1,460 | +439 | +43.00% |
09/19/2025 | CALL | $50.00 | 5,895 | +424 | +7.75% |
11/21/2025 | CALL | $52.50 | 2,071 | +305 | +17.27% |
08/15/2025 | CALL | $52.50 | 14,282 | +272 | +1.94% |
07/03/2025 | CALL | $48.00 | 1,309 | -242 | -15.60% |
07/11/2025 | CALL | $46.50 | 12 | -540 | -97.83% |
07/03/2025 | CALL | $47.00 | 0 | -707 | -100.00% |
07/18/2025 | CALL | $45.00 | 116 | -763 | -86.80% |
07/03/2025 | CALL | $46.50 | 0 | -784 | -100.00% |
08/15/2025 | CALL | $40.00 | 87 | -930 | -91.45% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.07% | 64.63M | 4.03B |
Vanguard 500 Index Fund | 2.34% | 49.15M | 3.06B |
Fidelity 500 Index Fund | 1.11% | 23.31M | 1.45B |
SPDR S&P 500 ETF Trust | 1.09% | 23.02M | 1.43B |
iShares Core S&P 500 ETF | 0.90% | 18.98M | 1.18B |
Vanguard Index-Value Index Fund | 0.87% | 18.37M | 1.14B |
JP Morgan Equity Income Fund | 0.82% | 17.35M | 1.08B |
Select Sector SPDR Fund-Health Care | 0.82% | 17.27M | 1.08B |
American Mutual Fund Inc | 0.78% | 16.49M | 1.03B |
Vanguard Institutional Index Fund-Institutional Index Fund | 0.71% | 14.9M | 927.91M |
FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers
06/27 11:34 am
Benzinga
Read more2 Beaten-Down Stocks to Avoid
06/27 08:15 am
The Motley Fool
Read moreMultiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight
06/24 01:00 pm
GlobeNewswire Inc.
Read moreICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen
06/21 06:20 am
GlobeNewswire Inc.
Read moreICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients
06/21 06:20 am
GlobeNewswire Inc.
Read moreEditas Medicine Is Great. Here's Why You Shouldn't Buy It.
06/17 10:07 am
The Motley Fool
Read more2 Beaten-Down Dividend Stocks to Buy Right Now
06/16 04:25 am
The Motley Fool
Read morePhilochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
06/10 05:55 pm
GlobeNewswire Inc.
Read moreRheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies
06/10 04:53 am
GlobeNewswire Inc.
Read moreDilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight
06/05 01:00 pm
GlobeNewswire Inc.
Read moreEpigenetics Market Anticipated to Achieve 11.8% CAGR
06/03 01:31 pm
GlobeNewswire Inc.
Read moreBristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug
06/02 10:14 am
Benzinga
Read moreBispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight
05/29 01:16 pm
GlobeNewswire Inc.
Read moreRapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
05/27 09:00 am
GlobeNewswire Inc.
Read moreGlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases
05/27 07:00 am
GlobeNewswire Inc.
Read moreTubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic
05/20 05:00 am
GlobeNewswire Inc.
Read moreBlood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight
05/12 01:00 pm
GlobeNewswire Inc.
Read moreU.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors
05/09 07:00 am
GlobeNewswire Inc.
Read moreFDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
05/06 03:21 pm
Benzinga
Read moreFDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
05/02 03:37 pm
Benzinga
Read moreThis High-Yield Pharma Stock Looks Like an Incredible Bargain
04/30 06:45 am
The Motley Fool
Read moreAnalysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate
04/30 04:56 am
GlobeNewswire Inc.
Read more4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
04/26 06:05 pm
The Motley Fool
Read moreBristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
04/24 11:55 am
Benzinga
Read moreThermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll
04/23 04:49 pm
Benzinga
Read moreIs High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?
04/15 07:39 am
The Motley Fool
Read moreThese Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?
04/13 11:33 am
Benzinga
Read moreSpecialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
04/10 01:58 pm
GlobeNewswire Inc.
Read moreBiopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline
04/10 05:59 am
GlobeNewswire Inc.
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read moreMinimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
04/08 04:48 am
GlobeNewswire Inc.
Read moreMPYS Protein Stimulants Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape
04/07 01:00 pm
GlobeNewswire Inc.
Read moreIs Bristol Myers Squibb's High-Yielding Dividend Safe?
04/02 05:40 am
The Motley Fool
Read moreTumor-infiltrating Lymphocyte (TIL) Therapies Global Market Report 2025: 75+ Therapies are Under Development and 100+ Clinical Trials are Underway Globally
04/01 02:44 pm
GlobeNewswire Inc.
Read moreBeat the S&P 500 With This Cash-Gushing Dividend Stock
04/01 08:00 am
The Motley Fool
Read moreWhy Pfizer Is My Largest Healthcare Position
03/27 06:45 am
The Motley Fool
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read more5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond
03/17 07:45 am
The Motley Fool
Read morePerspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 in Combination with Nivolumab in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
03/17 07:00 am
GlobeNewswire Inc.
Read more3 Stocks to Buy Amid Market Correction Triggered by Trump's Trade War
03/14 07:40 am
Investing.com
Read moreBristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
03/11 10:17 am
Benzinga
Read moreBristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis
03/10 12:54 pm
Benzinga
Read moreGlobal Prostate Cancer Market to Reach USD 29.2 Billion by 2035, Driven by Aging Population and Awareness | Future Market Insights, Inc.
03/09 08:30 pm
GlobeNewswire Inc.
Read moreAcetylcholine Receptor Antagonists Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
03/06 02:00 pm
GlobeNewswire Inc.
Read moreCancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection
03/06 05:55 am
GlobeNewswire Inc.
Read moreAdvanced Urothelial Carcinoma Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
03/03 02:00 pm
GlobeNewswire Inc.
Read moreInternational Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month
03/01 09:45 am
GlobeNewswire Inc.
Read moreGot $200? 2 Healthcare Stocks to Buy and Hold Forever
02/26 05:32 am
The Motley Fool
Read moreTALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight
02/24 02:00 pm
GlobeNewswire Inc.
Read moreBristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review
02/24 01:24 pm
Benzinga
Read more